Page 15 - Morphosys News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Morphosys. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Morphosys Today - Breaking & Trending Today
Monjuvi U.S. net product sales of US$ 20.8 million (€ 19.4 million) for the first quarter of 2023 Enrollment of Phase 3 MANIFEST-2 study of pelabresib in first-line myelofibrosis is complete, with topline ....
MorphoSys (NASDAQ:MOR – Get Rating) is set to release its earnings data after the market closes on Wednesday, May 3rd. Investors that are interested in registering for the company’s conference call can do so using this link. MorphoSys Trading Down 2.1 % Shares of MOR traded down $0.11 during trading hours on Tuesday, reaching $5.24. […] ....
MorphoSys AG (NASDAQ:MOR – Get Rating) was the target of a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 28,700 shares, a decline of 13.3% from the March 31st total of 33,100 shares. Based on an average daily volume of 111,400 shares, the short-interest […] ....
MorphoSys AG (ETR:MOR – Get Rating) shares were down 0.7% during trading on Thursday . The stock traded as low as €18.47 ($20.52) and last traded at €18.94 ($21.04). Approximately 88,739 shares were traded during trading, a decline of 42% from the average daily volume of 153,687 shares. The stock had previously closed at €19.08 […] ....
MorphoSys (NASDAQ:MOR – Get Rating) will be announcing its earnings results after the market closes on Wednesday, May 3rd. MorphoSys Trading Up 2.5 % Shares of MorphoSys stock opened at $5.29 on Friday. The company has a debt-to-equity ratio of 1.85, a current ratio of 3.91 and a quick ratio of 3.83. MorphoSys has a […] ....